Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

174 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prostate cancer prevention trials in the USA.
Brawley OW, Parnes H. Brawley OW, et al. Among authors: parnes h. Eur J Cancer. 2000 Jun;36(10):1312-5. doi: 10.1016/s0959-8049(00)00105-2. Eur J Cancer. 2000. PMID: 10882873 Review.
The future of prostate cancer prevention.
Brawley OW, Barnes S, Parnes H. Brawley OW, et al. Among authors: parnes h. Ann N Y Acad Sci. 2001 Dec;952:145-52. doi: 10.1111/j.1749-6632.2001.tb02735.x. Ann N Y Acad Sci. 2001. PMID: 11795434 Review.
Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
Lippman SM, Goodman PJ, Klein EA, Parnes HL, Thompson IM Jr, Kristal AR, Santella RM, Probstfield JL, Moinpour CM, Albanes D, Taylor PR, Minasian LM, Hoque A, Thomas SM, Crowley JJ, Gaziano JM, Stanford JL, Cook ED, Fleshner NE, Lieber MM, Walther PJ, Khuri FR, Karp DD, Schwartz GG, Ford LG, Coltman CA Jr. Lippman SM, et al. J Natl Cancer Inst. 2005 Jan 19;97(2):94-102. doi: 10.1093/jnci/dji009. J Natl Cancer Inst. 2005. PMID: 15657339
Chemoprevention in prostate cancer.
Parnes HL, Figg WD. Parnes HL, et al. Pharmacotherapy. 2006 Oct;26(10):1533; author reply 1533. doi: 10.1592/phco.26.10.1533. Pharmacotherapy. 2006. PMID: 16999665 No abstract available.
Finasteride and high-grade prostate cancer in the Prostate Cancer Prevention Trial.
Lucia MS, Epstein JI, Goodman PJ, Darke AK, Reuter VE, Civantos F, Tangen CM, Parnes HL, Lippman SM, La Rosa FG, Kattan MW, Crawford ED, Ford LG, Coltman CA Jr, Thompson IM. Lucia MS, et al. J Natl Cancer Inst. 2007 Sep 19;99(18):1375-83. doi: 10.1093/jnci/djm117. Epub 2007 Sep 11. J Natl Cancer Inst. 2007. PMID: 17848673 Clinical Trial.
Phase III prevention trial of fenretinide in patients with resected non-muscle-invasive bladder cancer.
Sabichi AL, Lerner SP, Atkinson EN, Grossman HB, Caraway NP, Dinney CP, Penson DF, Matin S, Kamat A, Pisters LL, Lin DW, Katz RL, Brenner DE, Hemstreet GP 3rd, Wargo M, Bleyer A, Sanders WH, Clifford JL, Parnes HL, Lippman SM. Sabichi AL, et al. Among authors: parnes hl. Clin Cancer Res. 2008 Jan 1;14(1):224-9. doi: 10.1158/1078-0432.CCR-07-0733. Clin Cancer Res. 2008. PMID: 18172274 Clinical Trial.
Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM, Ford LG, Parnes HL, Minasian LM, Gaziano JM, Hartline JA, Parsons JK, Bearden JD 3rd, Crawford ED, Goodman GE, Claudio J, Winquist E, Cook ED, Karp DD, Walther P, Lieber MM, Kristal AR, Darke AK, Arnold KB, Ganz PA, Santella RM, Albanes D, Taylor PR, Probstfield JL, Jagpal TJ, Crowley JJ, Meyskens FL Jr, Baker LH, Coltman CA Jr. Lippman SM, et al. Among authors: parnes hl. JAMA. 2009 Jan 7;301(1):39-51. doi: 10.1001/jama.2008.864. Epub 2008 Dec 9. JAMA. 2009. PMID: 19066370 Free PMC article. Clinical Trial.
174 results